Titre :
  • Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group.
Auteur : Paridaens, R. ; Dirix, Luc Y ; Beex, Louk ; Nooij, Marianne ; Cameron, David A ; Cufer, T ; Piccart-Gebhart, Martine ; Bogaerts, J ; Therasse, P.
Informations sur la publication : Journal of clinical oncology, 26, 30, (page 4883-4890)
Statut de publication : Publié, 2008-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged, 80 and over
Androstadienes -- therapeutic use
Antineoplastic Agents -- therapeutic use
Aromatase Inhibitors -- therapeutic use
Bone Neoplasms -- secondary
Breast Neoplasms -- drug therapy
Disease-Free Survival
Drug Resistance, Neoplasm
Estrogen Antagonists -- therapeutic use
Lymphatic Metastasis
Middle Aged
Soft Tissue Neoplasms -- secondary
Tamoxifen -- therapeutic use
Treatment Outcome
Note : Clinical Trial, Phase II
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X